Macieira Susana, Lussier Jacques, Bédard Christian
Department of Clinical Sciences, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Quebec.
Can J Vet Res. 2011 Jul;75(3):222-7.
Glanzmann thrombasthenia (GT) is characterized by a defect of platelet aggregation. This autosomal recessive genetic disorder is caused by an abnormality of the platelet glycoprotein receptors alpha IIb or beta III. Recently, we identified a horse with clinical and pathological features of GT. The aim of this study was to describe this case of GT at the molecular level. A point mutation from G to C in exon 2 of ITGA2B causing a substitution of the expected amino acid arginine 72 (Arg(72)) by a proline (Pro(72)) was encountered. This amino acid change may result in abnormal structural conformations that yield an inactive alpha IIb subunit. The genomic DNA analysis showed that this horse was homozygous for the missense mutation.
血小板无力症(GT)的特征是血小板聚集缺陷。这种常染色体隐性遗传病是由血小板糖蛋白受体αIIb或βIII异常引起的。最近,我们鉴定出一匹具有GT临床和病理特征的马。本研究的目的是在分子水平上描述这例GT病例。在ITGA2B基因外显子2中发现了一个从G到C的点突变,导致预期的氨基酸精氨酸72(Arg(72))被脯氨酸(Pro(72))取代。这种氨基酸变化可能导致产生无活性αIIb亚基的异常结构构象。基因组DNA分析表明,这匹马对于该错义突变为纯合子。